ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 21 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,893 | -94.1% | 1,100 | -91.9% | 0.00% | – |
Q1 2023 | $49,136 | -6.7% | 13,499 | 0.0% | 0.00% | – |
Q4 2022 | $52,646 | +2532.3% | 13,499 | +2689.0% | 0.00% | – |
Q3 2022 | $2,000 | -84.6% | 484 | -83.2% | 0.00% | – |
Q2 2022 | $13,000 | -89.7% | 2,884 | -87.2% | 0.00% | – |
Q1 2022 | $126,000 | – | 22,569 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |